澳股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Imagion Biosystems

0.007

0.000

成交量：145.65万

成交额：1.02万

市值：560.70万

市盈率：-0.64

高：0.007

开：0.007

低：0.007

收：0.007

52周最高：0.036

52周最低：0.006

股本：8.01亿

流通股本：1.72亿

量比：19.99

换手率：0.84%

股息：- -

股息率：- -

每股收益(TTM):-0.011

每股收益(LYR):-0.016

净资产收益率：-2804.87%

总资产收益率：-319.68%

市净率：-1.64

市盈率(LYR):-0.45

数据加载中...

总览公司新闻资讯公告

Imagion Biosystems获FDA二期临床试验许可后成功融资375万澳元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/IBX.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","market":"AU","secType":"STK","nameCN":"Imagion Biosystems","latestPrice":0.007,"timestamp":1791932828997,"preClose":0.007,"halted":0,"volume":1456499,"delay":0,"changeRate":0,"nameEN":"Imagion Biosystems","floatShares":172453894,"shares":801006908,"eps":-0.010968,"marketStatus":"交易中","change":0,"latestTime":"10-14 10:18:20 AEDT","open":0.007,"high":0.007,"low":0.007,"amount":10195,"amplitude":0,"askPrice":0.007,"askSize":4533994,"bidPrice":0.006,"bidSize":2133723,"shortable":3,"etf":0,"ttmEps":-0.010968,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791954000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.007,"openAndCloseTimeList":[[1791932400000,1791954000000]],"volumeRatio":19.991973,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IBX.AU","preClose":0.007,"auctionPrice":0.007,"auctionVolume":1456499,"auctionTime":1791932350096,"referenceTime":1791887404086,"auction":1,"marketStatus":"盘前竞价","timestamp":1791932350096}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IBX.AU\",,,,,undefined,":{"symbol":"IBX.AU","floatShares":172453894,"roa":"-319.68%","roe":"-2804.87%","lyrEps":-0.01553,"volumeRatio":19.991973,"shares":801006908,"dividePrice":0,"high":0.007,"amplitude":0,"preClose":0.007,"low":0.007,"week52Low":0.006,"pbRate":"-1.64","psRate":"9.78","week52High":0.036,"institutionHeld":0,"latestPrice":0.007,"committee":-0.359984,"eps":-0.010968,"divideRate":0,"volume":1456499,"delay":0,"ttmEps":-0.010968,"open":0.007,"prevYearClose":0.025,"prevWeekClose":0.006,"prevMonthClose":0.007,"prevQuarterClose":0.007,"fiveDayClose":0.006,"twentyDayClose":0.008,"sixtyDayClose":0.012,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-11-16","symbol":"IBX.AU","defaultRemindTime":1700089200000,"type":"split","dateTimestamp":1700053200000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185697396","title":"Imagion Biosystems获FDA二期临床试验许可后成功融资375万澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185697396","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185697396?lang=zh_cn&edition=fundamental","pubTime":"2026-06-25 23:52","pubTimestamp":1782402734,"startTime":"0","endTime":"0","summary":"在获得美国食品药品监督管理局（FDA）对其二期临床试验的许可后，Imagion Biosystems成功完成了375万澳元的资本募集。这一进展为公司的临床研究计划注入了关键资金，标志着其在医疗技术开发领域迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IBX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}